PTC299 Terminated Phase 1 Trials for Acute Myeloid Leukemia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03761069
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias